Summary of Study ST001632
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001043. The data can be accessed directly via it's Project DOI: 10.21228/M8W41Q This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST001632 |
| Study Title | Lipidomics of Ginseng Total Secondary Saponins on Myocardial Ischemia Rat |
| Study Summary | Cardioprotective Effect of Ginseng Total Secondary Saponins on Myocardial Ischemia Rat via Regulating Disturbed Lipids Based on Lipidomics. |
| Institute | Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College |
| Last Name | Wang |
| First Name | Zhe |
| Address | No.2 nanwei street, xichen district, Beijing, China |
| wangzhe@imm.ac.cn | |
| Phone | +861083154880 |
| Submit Date | 2020-11-22 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | d |
| Analysis Type Detail | LC-MS |
| Release Date | 2023-01-02 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR001043 |
| Project DOI: | doi: 10.21228/M8W41Q |
| Project Title: | Lipidomics of Ginseng Total Secondary Saponins on Myocardial Ischemia Rat |
| Project Summary: | Cardioprotective Effect of Ginseng Total Secondary Saponins on Myocardial Ischemia Rat via Regulating Disturbed Lipids Based on Lipidomics. |
| Institute: | Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College |
| Last Name: | Wang |
| First Name: | Zhe |
| Address: | No.2 nanwei street, xichen district, Beijing, China |
| Email: | wangzhe@imm.ac.cn |
| Phone: | +861083154880 |
Subject:
| Subject ID: | SU001709 |
| Subject Type: | Mammal |
| Subject Species: | Rattus norvegicus |
| Taxonomy ID: | 10116 |
| Genotype Strain: | Sprague-Dawley |
| Age Or Age Range: | 6 weeks-age |
| Weight Or Weight Range: | 200 ± 10 |
| Gender: | Male |
| Animal Animal Supplier: | Vital River Laboratories Co., Ltd (Beijng, China) |
| Animal Housing: | 25 ± 2℃, 50±5% relative humidity |
| Animal Light Cycle: | 12 h light/12 h dark photoperiod |
| Species Group: | Mammals |
Factors:
Subject type: Mammal; Subject species: Rattus norvegicus (Factor headings shown in green)
| mb_sample_id | local_sample_id | class | Tissue |
|---|---|---|---|
| SA138052 | 1-C5-HL | Control | heart |
| SA138053 | 1-A3-N-HL | Control | heart |
| SA138054 | 1-A5-N-HL | Control | heart |
| SA138055 | 1-B2-HL | Control | heart |
| SA138056 | 1-B1-HL | Control | heart |
| SA138057 | 1-A3-HL | Control | heart |
| SA138058 | 1-A5-HL | Control | heart |
| SA138059 | 1-B1-N-HL | Control | heart |
| SA138060 | 1-C5-N-HL | Control | heart |
| SA138061 | 1-B1-HS | Control | heart |
| SA138062 | 1-B2-HS | Control | heart |
| SA138063 | 1-B5-HS | Control | heart |
| SA138064 | 1-A5-HS | Control | heart |
| SA138065 | 1-A3-HS | Control | heart |
| SA138066 | 1-A1-HL | Control | heart |
| SA138067 | 1-A1-HS | Control | heart |
| SA138068 | 1-B2-N-HL | Control | heart |
| SA138069 | 1-A1-N-HL | Control | heart |
| SA138070 | 1-A3-PL | Control | plasma |
| SA138071 | 1-A2-PS | Control | plasma |
| SA138072 | 1-B3-PL | Control | plasma |
| SA138073 | 1-A3-N-PL | Control | plasma |
| SA138074 | 1-B2-PL | Control | plasma |
| SA138075 | 1-B5-PL | Control | plasma |
| SA138076 | 1-C1-PL | Control | plasma |
| SA138077 | 1-A5-N-PL | Control | plasma |
| SA138078 | 1-A5-PS | Control | plasma |
| SA138079 | 1-A3-PS | Control | plasma |
| SA138080 | 1-B2-PS | Control | plasma |
| SA138081 | 1-B5-PS | Control | plasma |
| SA138082 | 1-A5-PL | Control | plasma |
| SA138083 | 1-B5-N-PL | Control | plasma |
| SA138084 | 1-B3-N-PL | Control | plasma |
| SA138085 | 1-B3-PS | Control | plasma |
| SA138086 | 1-B2-N-PL | Control | plasma |
| SA138087 | 1-C1-N-PL | Control | plasma |
| SA138088 | 8-C5-HL | GTSS | heart |
| SA138089 | 8-A4-HL | GTSS | heart |
| SA138090 | 8-B2-HL | GTSS | heart |
| SA138091 | 8-B4-HL | GTSS | heart |
| SA138092 | 8-B2-N-HL | GTSS | heart |
| SA138093 | 8-B4-N-HL | GTSS | heart |
| SA138094 | 8-C5-N-HL | GTSS | heart |
| SA138095 | 8-A2-HL | GTSS | heart |
| SA138096 | 8-A4-N-HL | GTSS | heart |
| SA138097 | 8-A2-N-HL | GTSS | heart |
| SA138098 | 8-A1-N-HL | GTSS | heart |
| SA138099 | 8-A1-HL | GTSS | heart |
| SA138100 | 8-A2-HS | GTSS | heart |
| SA138101 | 8-A1-HS | GTSS | heart |
| SA138102 | 8-A4-HS | GTSS | heart |
| SA138103 | 8-B2-HS | GTSS | heart |
| SA138104 | 8-B3-HS | GTSS | heart |
| SA138105 | 8-C5-HS | GTSS | heart |
| SA138106 | 8-C2-N-PL | GTSS | plasma |
| SA138107 | 8-C4-PL | GTSS | plasma |
| SA138108 | 8-C4-N-PL | GTSS | plasma |
| SA138109 | 8-C1-N-PL | GTSS | plasma |
| SA138110 | 8-A1-N-PL | GTSS | plasma |
| SA138111 | 8-B2-PS | GTSS | plasma |
| SA138112 | 8-B3-PS | GTSS | plasma |
| SA138113 | 8-A2-N-PL | GTSS | plasma |
| SA138114 | 8-B3-N-PL | GTSS | plasma |
| SA138115 | 8-C2-PL | GTSS | plasma |
| SA138116 | 8-B3-PL | GTSS | plasma |
| SA138117 | 8-C2-PS | GTSS | plasma |
| SA138118 | 8-A1-PL | GTSS | plasma |
| SA138119 | 8-C1-PL | GTSS | plasma |
| SA138120 | 8-A2-PL | GTSS | plasma |
| SA138121 | 8-A2-PS | GTSS | plasma |
| SA138122 | 8-C4-PS | GTSS | plasma |
| SA138123 | 8-C5-PS | GTSS | plasma |
| SA138124 | 2-A3-HS | Model | heart |
| SA138125 | 2-A2-HS | Model | heart |
| SA138126 | 2-A4-HS | Model | heart |
| SA138127 | 2-C5-HS | Model | heart |
| SA138128 | 2-A1-HS | Model | heart |
| SA138129 | 2-A5-HS | Model | heart |
| SA138130 | 2-B2-N-HL | Model | heart |
| SA138131 | 2-A1-N-HL | Model | heart |
| SA138132 | 2-A1-HL | Model | heart |
| SA138133 | 2-A5-N-HL | Model | heart |
| SA138134 | 2-A5-HL | Model | heart |
| SA138135 | 2-B1-HL | Model | heart |
| SA138136 | 2-B3-HL | Model | heart |
| SA138137 | 2-B2-HL | Model | heart |
| SA138138 | 2-C5-HL | Model | heart |
| SA138139 | 2-B1-N-HL | Model | heart |
| SA138140 | 2-B3-N-HL | Model | heart |
| SA138141 | 2-C5-N-HL | Model | heart |
| SA138142 | 2-B1-N-PL | Model | plasma |
| SA138143 | 2-A1-N-PL | Model | plasma |
| SA138144 | 2-B4-N-PL | Model | plasma |
| SA138145 | 2-C3-N-PL | Model | plasma |
| SA138146 | 2-C4-N-PL | Model | plasma |
| SA138147 | 2-C1-N-PL | Model | plasma |
| SA138148 | 2-C1-PL | Model | plasma |
| SA138149 | 2-A4-PS | Model | plasma |
| SA138150 | 2-C4-PS | Model | plasma |
| SA138151 | 2-C3-PS | Model | plasma |
Collection:
| Collection ID: | CO001702 |
| Collection Summary: | Blood samples of the rats were collected to obtain plasma by centrifugation (3000r/min, 15 min) using heparin as an anticoagulant and kept at -80℃ until analysis. Hearts were collected, washed with cold saline and cut in half. One part was grinded into powder in liquid nitrogen and kept at -80℃. Heart samples were homogenized in saline on ice at the ratio of tissue to solution was 1:4 (w/v) before analysis. |
| Sample Type: | Heart |
Treatment:
| Treatment ID: | TR001722 |
| Treatment Summary: | Rats were divided into six rats in each group randomly as following: control rats group, MI model rats group, MI model rats pre-treated with diltiazem group (50 mg/kg, i.g.), and MI model rats pre-treated with GTSS group (200 mg/kg, i.g.). Pre-treated rats were consecutively administrated for 4 weeks. Except control rats group received saline, other rat groups received two injections of isoproterenol (85 mg/kg, s.c.) on the 27th and 28th days at an interval of 24 hours. |
Sample Preparation:
| Sampleprep ID: | SP001715 |
| Sampleprep Summary: | 100μl of plasma or tissue homogenate was transferred into a 10 ml glass tube and added 20 μl of lipid internal standards. After vortexed for 10 s, 1.5 ml of methanol and 5 ml methyl tert-butyl ether were added to the tube, and the sample was vortexed for 15 min and then added 1.5 ml water, then centrifuged at 4500r/min for 10 min (4 ℃). The upper organic phase was transferred to another glass tube, and the lower water phase was added with 2 ml secondary extractant (methyl tert-butyl ether /methanol/water,10:3:2.5, v/v/v). After vortexed for 10min and centrifuged for 15min at 4500rpm, and the upper organic phase was combined and dried under a gentle nitrogen stream. The residue was re-dissolved in 100 μl methanol/chloroform (1:1, v/v). |
Chromatography:
| Chromatography ID: | CH001962 |
| Instrument Name: | Agilent 1100 |
| Column Name: | Peeke C8 SR (150×3.0mm, 3μm) |
| Chromatography Type: | Reversed phase |
| Chromatography ID: | CH001963 |
| Instrument Name: | Thermo Accela 1250 |
| Column Name: | Waters Xterra MS C8 (100 x 2.1mm,3.5um) |
| Chromatography Type: | Reversed phase |
Analysis:
| Analysis ID: | AN002667 |
| Analysis Type: | MS |
| Chromatography ID: | CH001962 |
| Num Factors: | 6 |
| Num Metabolites: | 56 |
| Units: | pmol/ml(PL) & pmol/mg(HL) |
| Analysis ID: | AN002668 |
| Analysis Type: | MS |
| Chromatography ID: | CH001963 |
| Num Factors: | 6 |
| Num Metabolites: | 188 |
| Units: | pmol/ml(PS) & pmol/mg(HS) |